A 38-year-old woman from rural Maharashtra presents with a 3-month history of progressive fatigue, dyspnea on exertion, and recurrent oral ulcers. On examination, she is pale with petechiae over the lower limbs and hepatosplenomegaly. Laboratory investigations reveal: Hemoglobin 7.2 g/dL, WBC 2,100/μL, platelets 45,000/μL, reticulocyte count 0.8%, and normal B12 and folate levels. Bone marrow aspiration shows hypocellular marrow with 2% blasts. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Aplastic Anemia ### Key Clinical Features **Key Point:** This patient presents with the classic triad of pancytopenia: anemia (Hb 7.2), leukopenia (WBC 2,100), and thrombocytopenia (platelets 45,000) with a hypocellular bone marrow and low reticulocyte count. ### Diagnostic Criteria for Aplastic Anemia The diagnosis rests on three pillars: 1. **Pancytopenia** — all three cell lines depressed 2. **Hypocellular bone marrow** — cellularity typically <25% (this patient's marrow is hypocellular) 3. **Absence of dysplasia or fibrosis** — normal morphology, no increased blasts ### Why the Reticulocyte Count Matters **High-Yield:** A reticulocyte count of 0.8% in the setting of severe anemia (Hb 7.2) is **inappropriately low**. In hemolytic or bleeding anemias, the marrow would mount a brisk reticulocyte response (>5%). This low count confirms **bone marrow failure**, not peripheral destruction. ### Bone Marrow Findings | Feature | Aplastic Anemia | MDS | AML | |---------|-----------------|-----|-----| | Cellularity | <25% (hypocellular) | Variable (often normal/↑) | Usually ↑ | | Blasts | <5% | 5–19% | ≥20% | | Dysplasia | Absent | Present | Present | | Reticulocyte response | Low/absent | Low | Variable | **Clinical Pearl:** The 2% blasts rule out AML (which requires ≥20%) and are consistent with aplastic anemia (blasts <5%). ### Workup Algorithm for Pancytopenia ```mermaid flowchart TD A[Pancytopenia confirmed]:::outcome --> B[Reticulocyte count?]:::decision B -->|High| C[Hemolysis or bleeding]:::outcome B -->|Low| D[Bone marrow examination]:::action D --> E{Cellularity?}:::decision E -->|Hypocellular| F{Blasts, dysplasia?}:::decision E -->|Normocellular/Hypercellular| G[MDS or AML]:::outcome F -->|Absent| H[Aplastic anemia]:::action F -->|Present| I[MDS or AML]:::outcome ``` ### Etiology Considerations **Key Point:** In India, the most common causes of acquired aplastic anemia are: - Idiopathic (40–50%) - Drug-induced (chloramphenicol, NSAIDs, anticonvulsants) - Viral (hepatitis, EBV, parvovirus B19) - Occupational (benzene, pesticide exposure — relevant in rural setting) This patient's rural background and no clear drug history suggest possible environmental or viral etiology. ### Severity Grading (Camitta Criteria) This patient meets criteria for **severe aplastic anemia** (bone marrow cellularity <25% + at least 2 of: Hb <10, platelets <20,000, ANC <500). **High-Yield:** Severity determines prognosis and treatment — severe aplastic anemia requires urgent hematopoietic stem cell transplantation or immunosuppressive therapy.